| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,320,000 |
| Market
Cap: |
3.39(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$57.42 - $97.64 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Axsome Therapeutics is a biopharmaceutical company developing therapies for the management of central nervous system (CNS) conditions that have limited treatment options. Co.'s primary CNS portfolio includes: AXS-05, which is an oral, investigational N-methyl-D-aspartate receptor antagonist with multimodal activity under development for the treatment of CNS disorders; AXS-07, which is an oral, multi-mechanistic, investigational medicine under development for the acute treatment of migraine; AXS-12, which is an oral, investigational medicine in development for the treatment of narcolepsy; and AXS-14, which is an oral, investigational medicine in development for the treatment of fibromyalgia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
56,985 |
56,985 |
86,573 |
86,573 |
| Total Sell Value |
$4,162,391 |
$4,162,391 |
$6,386,821 |
$6,386,821 |
| Total People Sold |
2 |
2 |
3 |
3 |
| Total Sell Transactions |
3 |
3 |
5 |
5 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jacobson Mark L. |
Chief Operating Officer |
• – – |
2024-04-01 |
4 |
AS |
$77.24 |
$1,904,942 |
D/D |
(24,662) |
0 |
|
-7% |
|
| Jacobson Mark L. |
Chief Operating Officer |
• – – |
2024-04-01 |
4 |
OE |
$1.30 |
$32,061 |
D/D |
24,662 |
24,662 |
|
- |
|
| Jeffs Roger |
|
– • – |
2024-03-15 |
4 |
AS |
$71.61 |
$168,062 |
D/D |
(2,347) |
120,756 |
|
-5% |
|
| Jeffs Roger |
|
– • – |
2024-03-15 |
4 |
OE |
$29.91 |
$70,199 |
D/D |
2,347 |
123,103 |
|
- |
|
| Jeffs Roger |
|
– • – |
2024-03-14 |
4 |
AS |
$69.70 |
$2,089,387 |
D/D |
(29,976) |
120,756 |
|
3% |
|
| Jeffs Roger |
|
– • – |
2024-03-14 |
4 |
OE |
$22.03 |
$719,787 |
D/D |
29,976 |
137,732 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2023-09-15 |
4 |
AS |
$75.18 |
$1,396,189 |
I/I |
(18,572) |
403,856 |
|
20% |
|
| Coleman Mark |
Director |
– • – |
2023-09-15 |
4 |
AS |
$75.19 |
$828,241 |
D/D |
(11,016) |
25,097 |
|
20% |
|
| Coleman Mark |
Director |
– • – |
2023-09-15 |
4 |
OE |
$3.67 |
$40,429 |
D/D |
11,016 |
36,113 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2023-01-03 |
4 |
OE |
$1.30 |
$22,751 |
D/D |
17,501 |
25,097 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2022-03-15 |
4 |
OE |
$1.30 |
$4,545 |
D/D |
3,496 |
7,596 |
|
- |
|
| Jeffs Roger |
Director |
– • – |
2021-11-19 |
4 |
B |
$37.30 |
$147,350 |
D/D |
3,950 |
120,756 |
2.39 |
30% |
|
| Saad Mark E |
Director |
– • – |
2021-11-17 |
4 |
B |
$34.40 |
$10,325 |
I/I |
300 |
100 |
2.1 |
20% |
|
| Saad Mark E |
Director |
– • – |
2021-11-17 |
4 |
B |
$34.53 |
$103,597 |
D/D |
3,000 |
10,002 |
2.39 |
20% |
|
| Coleman Mark |
Director |
– • – |
2021-05-12 |
4 |
B |
$58.15 |
$29,075 |
I/I |
500 |
420,998 |
2.1 |
-45% |
|
| Coleman Mark |
Director |
– • – |
2020-08-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
397,998 |
397,998 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2020-08-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
397,998 |
5,700 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2020-06-29 |
4 |
B |
$78.50 |
$51,025 |
D/D |
650 |
403,698 |
2.39 |
-10% |
|
| Pizzie Nick |
Chief Financial Officer |
• – – |
2020-06-29 |
4 |
B |
$76.64 |
$59,549 |
D/D |
777 |
41,217 |
2.74 |
-10% |
|
| Jeffs Roger |
Director |
– • – |
2020-01-10 |
4 |
OE |
$4.95 |
$629,756 |
D/D |
60,186 |
116,806 |
|
- |
|
| Pizzie Nick |
Chief Financial Officer |
• – – |
2019-09-26 |
4 |
B |
$24.80 |
$54,064 |
D/D |
2,180 |
40,440 |
2.74 |
- |
|
| Jeffs Roger |
Director |
– • – |
2019-07-03 |
4 |
OE |
$2.85 |
$172,178 |
D/D |
56,620 |
56,620 |
|
- |
|
| Coleman Mark |
Director |
– • – |
2019-06-26 |
4 |
B |
$23.10 |
$364,980 |
D/D |
15,800 |
668,848 |
2.39 |
- |
|
| Coleman Mark |
Director |
– • – |
2019-06-25 |
4 |
B |
$23.25 |
$9,300 |
D/D |
400 |
653,048 |
2.39 |
- |
|
| Pizzie Nick |
Chief Financial Officer |
• – – |
2019-06-11 |
4 |
B |
$20.80 |
$39,936 |
D/D |
1,920 |
1,920 |
2.74 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.19 (0.27%) 
